WINTER 2006
IN THIS ISSUE

    MESSAGE FROM THE CEO
    UP CLOSE
    BIRD FLU LIABILITY
    NEWS YOU CAN USE

 
UpClose
Ken Dowell, Pharmacy Practice Leader, Evergreen Rx


What’s Your Generic Strategy?

Over the next two years, 16 blockbuster brand-name medications—representing more than 12% of drug spend—will be coming off patent. Generic substitutions have the potential of generating more than $2 billion in estimated savings.

According to recent published reports, consumers are increasingly confident about using generic drugs as a safe and effective alternative to brand-name drugs. Considering generics can cost up to 75 per cent less than their brand-name counterparts, having a strategy to transition members to generics as they become available can significantly lower drug spend.

Read More

A Message from the CEO
by Charles Crispin, President & CEO, Evergreen Re

Evergreen Re had a banner 2005, growing by more than 40 per cent. To us having the greatest year ever means 98.5 per cent of all our existing clients renewed or have retained us as their reinsurance broker. We also have added more than 50 new clients, including a growing number of health plans which have chosen our pharmacy consultancy, Evergreen Rx to help them manage their PBM contracts and relationships.

We are especially proud to have received an exclusive endorsement for Evergreen Rx from the nation’s premier health insurance association, America’s Health Insurance Plans (AHIP). As an AHIP Solutions Partner, Evergreen Rx is poised to continue to grow as more attention is focused on the cost of prescription drugs and the implementation of the new Medicare Part D program.

Read More